Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income and Growth VCT 2 Regulatory News (MIG2)

Share Price Information for Maven Income and Growth VCT 2 (MIG2)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
MIG2 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income and Growth VCT 2 Share Chart

Interim Management Statement

11 Dec 2009 11:41

RNS Number : 9870D
Aberdeen Growth VCT1 PLC
11 December 2009
 



Aberdeen Growth VCT I PLC (the Company)

Interim Management Statement - Quarter ended 31 October 2009

This Interim Management Statement, for the quarter ended 31 October 2009, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 November 2009 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1. Financial highlights
 
·; Net Asset Value (NAV)1 of 54.3p at 31 October 2009; compared to 52.7p at 31 July 2009 and representing an increase of 3.0% over the period.
 
·; Interim dividend of 1p per share, in respect of the year ending 31 January 2010, paid on 13 November 2009.
 
1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 October 2009. Unlisted companies are normally valued on a six-monthly basis; the NAV incorporates the Directors' valuation of unlisted investments as at 31 July 2009, adjusted for subsequent events where appropriate. 
 
2. Investments and disposals
 
Three unlisted investments were completed during the quarter ended 31 October 2009 at a total cost of £152,000. In the same period, the disposal of three unlisted holdingsand one AIM quoted investment generated aggregate proceeds of £1,086,000 against a cost of £899,000. In addition, following the striking-off of Dipford Group and Transrent Holdings by the Registrar of Companies, aggregate losses of £1,064,000 which had already been fully provided for were realised, with there being no resulting impact on the Company's Net Asset Value.
 
3. Recent developments 
 
Between 31 October 2009 and the date of this statement, investments totalling £202,000 were made in one unlisted and two AIM quoted companies.
 
During the same post quarter-end period, disposals of four unlisted and one AIM quoted investments generated aggregate proceeds of £818,000 against cost of £464,000. 
 
4. Change of Company Name
 
At a General Meeting of the Company held on 9 December 2009, Shareholders approved a change in the name of the Company to Maven Income and Growth VCT 2 PLC with this change to become effective once receipt of the Resolution has been confirmed by Companies House.

Other than described above and the impact of movements related to the prices of shares in quoted securities, the Board is not aware of any material events during the period from 1 August 2009 to 31 October 2009, or in the period from 1 November 2009 to the date of this announcement, which would have had a material impact on the financial position of the Company.

Issued on behalf of the Board

Maven Capital Partners UK LLP

Secretary

11 December 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGCWPUPBGGG
Date   Source Headline
17th Jun 20151:04 pmRNSDirectorate Change
17th Jun 20151:02 pmRNSResult of AGM
8th May 20155:00 pmRNSAnnual Financial Report
13th Apr 20153:08 pmRNSIssue of Equity
27th Mar 20159:55 amRNSNet Asset Value(s)
26th Feb 201512:09 pmRNSIssue of Equity
26th Feb 201510:57 amRNSDirector/PDMR Shareholding
20th Feb 20152:46 pmRNSIssue of Equity
5th Feb 20155:00 pmRNSStatement re Offers for Subscription
3rd Feb 20153:07 pmRNSStatement re Offers for Subscription
30th Jan 20154:53 pmRNSStatement re Offers for Subscription
20th Jan 20159:48 amRNSStatement re Offers for Subscription
9th Jan 20154:25 pmRNSTransaction in Own Shares
7th Jan 20154:33 pmRNSTransaction in Own Shares
7th Jan 20152:11 pmRNSStatement re Offers for Subscription
16th Dec 20141:36 pmRNSNet Asset Value(s)
20th Oct 20146:27 pmRNSStatement re Prospectus and Circular
3rd Oct 20144:21 pmRNSTotal Voting Rights
1st Oct 201410:50 amRNSStatement re Joint Offer for Subscription
30th Sep 20143:23 pmRNSHalf Yearly Report
4th Jul 20145:11 pmRNSTransaction in Own Shares
4th Jul 20144:31 pmRNSReplacement re Issue of Equity
2nd Jul 20149:48 amRNSIssue of Equity
1st Jul 20143:44 pmRNSTransaction in Own Shares
30th Jun 20144:30 pmRNSTransaction in Own Shares
30th Jun 20142:59 pmRNSTransaction in Own Shares
26th Jun 20143:25 pmRNSTransaction in Own Shares
25th Jun 20143:53 pmRNSTransaction in Own Shares
19th Jun 20144:17 pmRNSInterim Management Statement
18th Jun 20142:38 pmRNSResult of AGM
28th May 20145:09 pmRNSOffer for Subscription Update
30th Apr 20147:01 amRNSStatement re Offer for Subscription
24th Apr 20142:46 pmRNSOffer for Subscription - Supplementary Prospectus
14th Apr 20142:26 pmRNSAnnual Financial Report
10th Apr 201412:03 pmRNSTransaction in Own Shares
9th Apr 20143:32 pmRNSDirector/PDMR Shareholding
8th Apr 20144:46 pmRNSDirector/PDMR Shareholding
7th Apr 20144:14 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:28 amRNSIssue of Equity
31st Mar 20147:00 amRNSStatement re NAV, Dividend and Offer Price
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary prospectus
13th Feb 201410:41 amRNSDirector/PDMR Shareholding
10th Feb 20146:03 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:21 pmRNSIssue of Equity
13th Dec 20132:50 pmRNSInterim Management Statement
27th Nov 20131:59 pmRNSReplacement Result of General Meeting
27th Nov 20131:34 pmRNSResult of EGM
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20134:47 pmRNSTransaction in Own Shares
8th Oct 20132:07 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.